Skip to main content
twitter
facebook
linkedin
Newsroom
Subscribe
Contact
Hit enter to search or ESC to close
Close Search
Menu
About
Company Overview
Team
Careers
Science
Pipeline
Investors
Investor Overview
Press Releases
Events + Presentations
Company Information
SEC Filings
Stock Information
Corporate Governance
News Alerts
Investors
Press Releases
Overview
Press Releases
Events + Presentations
Company Information
Stock Information
SEC Filings
Corporate Governance
News Alerts
Recent Press Releases
Enveric Biosciences to Present at the 6th Annual Neuroscience Innovation Forum and Biotech Showcase during “J.P. Morgan Health Care Week 2023”
December 21, 2022
Enveric Biosciences Announces Confidential Submission of Registration Statement for the Spin-off of its Cannabinoid Business to Shareholders
November 28, 2022
Enveric Biosciences to Participate in A.G.P.’s Virtual Biotech Conference
November 16, 2022
Enveric Biosciences to Participate in Wonderland: Miami on November 3-5, 2022
November 1, 2022
Enveric Biosciences Advances Lead Candidate for the Treatment of Anxiety Disorders to IND-Enabling Studies
October 24, 2022
Enveric Biosciences Announces Poster Presentations of Lead Programs at the 2022 International Neurology & Brain Disorders Conference
October 12, 2022
View All Press Releases
Close Menu
About
Company Overview
Team
Careers
Science
Pipeline
Investors
Investor Overview
Press Releases
Events + Presentations
Company Information
SEC Filings
Stock Information
Corporate Governance
News Alerts
Newsroom
Subscribe
Contact